Literature DB >> 22198389

Fusion of bone marrow-derived cells with renal tubules contributes to renal dysfunction in diabetic nephropathy.

Tomohisa Yamashita1, Mineko Fujimiya, Kanna Nagaishi, Koji Ataka, Marenao Tanaka, Hideaki Yoshida, Kazufumi Tsuchihashi, Kazuaki Shimamoto, Tetsuji Miura.   

Abstract

Although diabetic nephropathy (DN) is a major cause of end-stage renal disease, the mechanism of dysfunction has not yet been clarified. We previously reported that in diabetes proinsulin-producing bone marrow-derived cells (BMDCs) fuse with hepatocytes and neurons. Fusion cells are polyploidy and produce tumor necrosis factor (TNF)-α, ultimately causing diabetic complications. In this study, we assessed whether the same mechanism is involved in DN. We performed bone marrow transplantation from male GFP-Tg mice to female C57BL/6J mice and produced diabetes by streptozotocin (STZ) or a high-fat diet. In diabetic kidneys, massive infiltration of BMDCs and tubulointerstitial injury were prominent. BMDCs and damaged tubular epithelial cells were positively stained with proinsulin and TNF-α. Cell fusion between BMDCs and renal tubules was confirmed by the presence of Y chromosome. Of tubular epithelial cells, 15.4% contain Y chromosomes in STZ-diabetic mice, 8.6% in HFD-diabetic mice, but only 1.5% in nondiabetic mice. Fusion cells primarily expressed TNF-α and caspase-3 in diabetic kidney. These in vivo findings were confirmed by in vitro coculture experiments between isolated renal tubular cells and BMDCs. It was concluded that cell fusion between BMDCs and renal tubular epithelial cells plays a crucial role in DN.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22198389     DOI: 10.1096/fj.11-183194

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  9 in total

1.  Diabetes impairs the interactions between long-term hematopoietic stem cells and osteopontin-positive cells in the endosteal niche of mouse bone marrow.

Authors:  Hironori Chiba; Koji Ataka; Kousuke Iba; Kanna Nagaishi; Toshihiko Yamashita; Mineko Fujimiya
Journal:  Am J Physiol Cell Physiol       Date:  2013-07-24       Impact factor: 4.249

Review 2.  Emerging roles of hematopoietic cells in the pathobiology of diabetic complications.

Authors:  Hideto Kojima; Jongoh Kim; Lawrence Chan
Journal:  Trends Endocrinol Metab       Date:  2014-02-04       Impact factor: 12.015

3.  Noncanonical Mechanisms for Direct Bone Marrow Generating Ang II (Angiotensin II) Predominate in CD68 Positive Myeloid Lineage Cells.

Authors:  Tomohisa Yamashita; Sarfaraz Ahmad; Kendra N Wright; Drew J Roberts; Jessica L VonCannon; Hao Wang; Leanne Groban; Louis J Dell'Italia; Carlos M Ferrario
Journal:  Hypertension       Date:  2019-12-09       Impact factor: 10.190

Review 4.  It is all in the blood: the multifaceted contribution of circulating progenitor cells in diabetic complications.

Authors:  Gian Paolo Fadini; Angelo Avogaro
Journal:  Exp Diabetes Res       Date:  2012-04-03

5.  Amniotic Fluid Derived Stem Cells with a Renal Progenitor Phenotype Inhibit Interstitial Fibrosis in Renal Ischemia and Reperfusion Injury in Rats.

Authors:  Marina Gabriela Monteiro Carvalho Mori da Cunha; Silvia Zia; Fanny Oliveira Arcolino; Marianne Sylvia Carlon; Diego Vilibaldo Beckmann; Ney Luis Pippi; Dominguita Luhers Graça; Elena Levtchenko; Jan Deprest; Jaan Toelen
Journal:  PLoS One       Date:  2015-08-21       Impact factor: 3.240

6.  Mesenchymal stem cell therapy ameliorates diabetic nephropathy via the paracrine effect of renal trophic factors including exosomes.

Authors:  Kanna Nagaishi; Yuka Mizue; Takako Chikenji; Miho Otani; Masako Nakano; Naoto Konari; Mineko Fujimiya
Journal:  Sci Rep       Date:  2016-10-10       Impact factor: 4.379

Review 7.  Rebuilding the Missing Part-A Review on Photoreceptor Transplantation.

Authors:  Tiago F Santos-Ferreira; Oliver Borsch; Marius Ader
Journal:  Front Syst Neurosci       Date:  2017-01-05

8.  Mitochondria transfer from mesenchymal stem cells structurally and functionally repairs renal proximal tubular epithelial cells in diabetic nephropathy in vivo.

Authors:  Naoto Konari; Kanna Nagaishi; Shin Kikuchi; Mineko Fujimiya
Journal:  Sci Rep       Date:  2019-03-26       Impact factor: 4.379

9.  Long noncoding RNA MIAT inhibits the progression of diabetic nephropathy and the activation of NF-κB pathway in high glucose-treated renal tubular epithelial cells by the miR-182-5p/GPRC5A axis.

Authors:  Qianlan Dong; Qiong Wang; Xiaohui Yan; Xiaoming Wang; Zhenjiang Li; Linping Zhang
Journal:  Open Med (Wars)       Date:  2021-09-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.